Global Smart Syringes Market
Global Smart-Syringes-Market was valued at USD 8.2 billion in2020 and expected to reach USD 16.2 billion by 2030 at a CAGR 8.6% from 2020-2030.
Smart syringes are defined as type of medical devices which are engineered with safety mechanisms to prevent the reuse of syringes & regulate unsafe injection practices. These syringes are equipped with features to avoid needlestick injuries in a patient who uses these syringes and avoid transmission of blood-borne diseases like hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). They cater to numerous applications including vaccination, drug delivery, and blood specimen collection.
Market Drivers
The global smart syringes market growth is registered on account of the growing prevalence of target diseases, the rise in number of vaccinations, and the growth of geriatric population. Also, the increase in need to prevent hospital or clinic acquired infections will positively influence the market growth. Smart syringes are widely used in the filed of vaccination, blood specimen collection, and drug delivery. Vaccination is an important form of prevention and it is used for administrating the antigenic substance to produce immunity to a particular disease. Numerous diseases such as smallpox & polio have been successfully exterminated through the vaccination.
As per the WHO smart syringes are designed to protect the person administering the injection & to prevent the syringe from being used more than once. Government & NGO are taking initiatives to promote the awareness regarding safety & precaution of syringes in different developing countries across the globe. For instance, World Health Organization had launched a policy on injection safety & to block the use of unsafe injections. New WHO safety guidelines & policy offers detailed recommendations highlighting the value of safety features for syringes, including devices which protect health workers against accidental needle injury & consequent exposure to infection.
Market Restraints
High cost of smart syringes, especially passive safety syringes as well as lack of awareness in developing nations, and alternative drug delivery methods are expected to hinder the global smart syringes market growth.
Impact of COVID-19
Volume of smart syringes to be used in upcoming years is anticipated to witness a sharp increase, due to the COVID-19 immunization programs which are pre-planned across the globe. COVID-19 infection has already proven its ability to create medical equipment shortages like supply of face masks, gowns, and PPE (personal protective equipment) within early days of the crisis. Thus, to overcome such supply chain issues, governments & private organizations have already started manufacturing of syringes, as they are one of the essential components of vaccine delivery. This demand for global vaccination against Covid-19 is wholly prepared to fuel smart syringe manufacturing throughout the pandemic period.
Market Segmentation
The Global Smart Syringes Market is segmented into product type such as Auto-disable syringes, Active safety syringes, and Passive safety syringes, by application such as Vaccination, Blood Specimen Collection, and Drug delivery. Further, market is segmented into Hospitals & HMOs, Family practices (Physicians), Diabetic patients, Psychiatrics and, Others.
Also, the Global Smart Syringes Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Regional Analysis
The North America is expected to hold highest market share in the global smart syringe market followed by Europe, and Asia-Pacific. Europe is the second largest market and it is projected to be the most significant revenue contributor over the forecast period. Due to the several developments in the healthcare industry in the countries like Germany, France, and Spain. The APAC is expected to be an emerging market for the smart syringes market, and is anticipated to register highest CAGR in throughout the forecasted period, due to the increase demand for minimal invasive medical procedure & growing healthcare expenditure in the region.
Key Players
Some key operating players are listed in this report such as Becton, Dickinson and Company, Gerresheimer AG, Baxter, Terumo Corporation, B. Braun Melsungen AG, AdvaCare Pharma, Cardinal Health, Parker Hannifin Corp, Numedico Technologies Pty Ltd, Retractable Technologies, Inc., etc.
Market Taxonomy
By Product Type
By Application
By End User
By Region
Key Questions Addressed by the Report
Global Smart Syringes Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Smart Syringes Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Smart Syringes Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Smart Syringes Market Share Analysis, By Product Type
5.3 Global Smart Syringes Market Size and Forecast, By Product Type
5.3.1 Auto-disable syringes
5.3.2. Active safety syringes
5.3.3. Passive safety syringes
6 Global Smart Syringes Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Smart Syringes Market Share Analysis, By Application
6.3 Global Smart Syringes Market Size and Forecast, By Application
6.3.1 Vaccination
6.3.2. Blood Specimen Collection
6.3.3. Drug delivery
7 Global Smart Syringes Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Smart Syringes Market Share Analysis, By End User
7.3 Global Smart Syringes Market Size and Forecast, By End User
7.3. 1 Hospitals & HMOs
7.3.2. Family practices (Physicians)
7.3.3. Diabetic patients
7.3.4. Psychiatrics
7.3.5. Others
8Global Smart Syringes Market, By Region
8.1 Global Smart Syringes Market Share Analysis, By Region
8.2 Global Smart Syringes Market Share Analysis, By Region
8.3 Global Smart Syringes Market Size and Forecast, By Region
9 North America Smart Syringes Market Analysis and Forecast (2020-2030)
9.1 Introduction
9.2 North America Smart Syringes Market Share Analysis, By Product Type
9.3 North America Smart Syringes Market Size and Forecast, By Application
9.4 North America Smart Syringes Market Size and Forecast, By End User
9.5 North America Smart Syringes Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10EuropeSmart Syringes Market Analysis and Forecast (2020-2030)
10.1 Introduction
10.2 Europe Smart Syringes Market Share Analysis, By Product Type
10.3 Europe Smart Syringes Market Size and Forecast, By Application
10.4 Europe Smart Syringes Market Size and Forecast, By End User
10.5 Europe Smart Syringes Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Smart Syringes Market Analysis and Forecast (2020-2030)
11.1 Introduction
11.2 Asia Pacific Smart Syringes Market Share Analysis, By Product Type
11.3 Asia Pacific Smart Syringes Market Size and Forecast, By Application
11.4 Asia Pacific Smart Syringes Market Size and Forecast, By End User
11.5 Asia Pacific Smart Syringes Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Smart Syringes Market Analysis and Forecast (2020-2030)
12.1 Introduction
12.2 Latin America Smart Syringes Market Share Analysis, By Product Type
12.3 Latin America Smart Syringes Market Size and Forecast, By Application
12.4 Latin America Smart Syringes Market Size and Forecast, By End User
12.5 Latin America Smart Syringes Market Size and Forecast, Country
13Middle East Smart Syringes Market Analysis and Forecast (2020-2030)
13.1 Introduction
13.2 Middle East Smart Syringes Market Share Analysis, By Product Type
13.3 Middle East Smart Syringes Market Size and Forecast, By Application
13.4 Middle East Smart Syringes Market Size and Forecast, By End User
13.5 Middle East Smart Syringes Market Size and Forecast, By Country
14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15Company Profiles
15.1 Becton, Dickinson and Company
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Gerresheimer AG
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Baxter
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Terumo Corporation
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 B. Braun Melsungen AG
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 AdvaCare Pharma
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Cardinal Health
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Parker Hannifin Corp
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Numedico Technologies Pty Ltd
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Retractable Technologies, Inc
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
